Kemwell Biopharma

Kemwell is a contract biologics development and CMO company providing services to global biopharmaceutical organizations. Kemwell facilities, located in Bangalore, India, are designed and developed with technological support from a leading German pharma company. Kemwell provides customers with cost-effective access to state-of-the-art technology for all mammalian cell culture based products development and manufacturing. 15,000 sq. m. Kemwell facility consists of a cGMP drug substance manufacturing area with over 4500L bioreactor capacity, sterile fill and finish areas for cGMP drug product manufacturing and process development laboratories to support production of protein therapeutics from mammalian-cell culture monoclonal antibodies, bi-specific antibodies, fusion proteins,...

Contract analytical services,contract biopharmaceutical development,contract biopharmaceutical manufacturing,drug product manufacturing,cdmo,cmo,biologics,monoclonal antibodies,fusion protein,bispecific antibody,fill-finish,liquid injectable,lyophilised injectable,process development ,analytical development,and quality control

Kemwell biopharma operates in the Biotechnology industry.

Kemwell biopharma's revenue is 11m - 100m

Kemwell biopharma has 501 - 1000 employees.